TP53 and familial pancreatic carcinoma: Additionally, ALKBH5 levels were found to be elevated in the wild‐type p53 group, while the p53 mutation group exhibited low levels of ALKBH5 in pancreatic cancer, as revealed by the analysis of TCGA datasets.